Details

Re-evaluation decision RVD2024-02, Bacillus amyloliquefaciens strain MBI 600 and Bacillus subtilis strain QST 713 and their associated end-use products - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Apr 18, 2025 · edition #1
Timestamp
2025-04-18T21:04:17.681Z
Language
en
ID
160965
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview